{"status": "Succeeded", "recognitionResults": [{"page": 1, "clockwiseOrientation": 0.06, "width": 1700, "height": 2280, "unit": "pixel", "lines": [{"boundingBox": [1022, 100, 1452, 102, 1451, 135, 1021, 134], "text": "Trimegestone Publication Strategy", "words": [{"boundingBox": [1027, 101, 1193, 103, 1193, 135, 1026, 134], "text": "Trimegestone"}, {"boundingBox": [1199, 103, 1346, 103, 1346, 136, 1199, 135], "text": "Publication"}, {"boundingBox": [1352, 103, 1451, 102, 1452, 136, 1353, 136], "text": "Strategy"}]}, {"boundingBox": [250, 316, 1144, 317, 1143, 367, 249, 366], "text": "BASIC MESSAGES RELATING TO", "words": [{"boundingBox": [253, 319, 413, 318, 413, 365, 253, 365], "text": "BASIC"}, {"boundingBox": [434, 318, 737, 317, 737, 365, 435, 365], "text": "MESSAGES"}, {"boundingBox": [752, 317, 1040, 317, 1039, 367, 752, 365], "text": "RELATING"}, {"boundingBox": [1070, 317, 1131, 317, 1130, 367, 1069, 367], "text": "TO"}]}, {"boundingBox": [252, 415, 967, 414, 968, 462, 253, 463], "text": "ALL TOTELLE PRODUCTS", "words": [{"boundingBox": [257, 416, 360, 415, 359, 463, 256, 463], "text": "ALL"}, {"boundingBox": [385, 415, 644, 415, 642, 464, 384, 463], "text": "TOTELLE"}, {"boundingBox": [659, 415, 967, 415, 965, 464, 657, 464], "text": "PRODUCTS"}]}, {"boundingBox": [249, 633, 1459, 632, 1460, 666, 249, 667], "text": "(1) Totelle products, in long-term use, offer an effective range of options for the prevention of", "words": [{"boundingBox": [249, 633, 295, 633, 296, 665, 250, 664], "text": "(1)", "confidence": "Low"}, {"boundingBox": [301, 633, 389, 634, 390, 666, 303, 665], "text": "Totelle"}, {"boundingBox": [395, 634, 513, 634, 514, 667, 396, 666], "text": "products,"}, {"boundingBox": [519, 634, 547, 634, 548, 667, 520, 667], "text": "in"}, {"boundingBox": [553, 634, 671, 634, 672, 667, 555, 667], "text": "long-term"}, {"boundingBox": [686, 634, 741, 634, 742, 668, 687, 667], "text": "use,"}, {"boundingBox": [747, 634, 810, 634, 811, 668, 748, 668], "text": "offer"}, {"boundingBox": [816, 634, 848, 634, 849, 668, 817, 668], "text": "an"}, {"boundingBox": [856, 634, 966, 634, 967, 667, 857, 668], "text": "effective"}, {"boundingBox": [972, 634, 1046, 634, 1046, 667, 973, 667], "text": "range"}, {"boundingBox": [1052, 634, 1082, 634, 1083, 667, 1052, 667], "text": "of"}, {"boundingBox": [1088, 634, 1184, 634, 1185, 666, 1089, 667], "text": "options"}, {"boundingBox": [1190, 634, 1228, 634, 1229, 666, 1191, 666], "text": "for"}, {"boundingBox": [1235, 634, 1275, 634, 1276, 665, 1235, 666], "text": "the"}, {"boundingBox": [1281, 634, 1418, 633, 1418, 663, 1282, 665], "text": "prevention"}, {"boundingBox": [1426, 633, 1458, 633, 1459, 663, 1426, 663], "text": "of"}]}, {"boundingBox": [295, 686, 547, 688, 547, 716, 294, 714], "text": "osteoporotic disease", "words": [{"boundingBox": [300, 690, 452, 688, 453, 715, 300, 712], "text": "osteoporotic"}, {"boundingBox": [461, 688, 546, 690, 547, 716, 462, 715], "text": "disease"}]}, {"boundingBox": [251, 765, 1456, 767, 1455, 801, 250, 799], "text": "(2) The progestin component of Totelle products, trimegestone, has high affinity and specificity", "words": [{"boundingBox": [251, 767, 295, 768, 295, 798, 251, 798], "text": "(2)"}, {"boundingBox": [303, 768, 349, 768, 349, 798, 303, 798], "text": "The"}, {"boundingBox": [355, 768, 475, 768, 475, 798, 355, 798], "text": "progestin"}, {"boundingBox": [481, 768, 621, 768, 620, 799, 481, 798], "text": "component"}, {"boundingBox": [627, 768, 659, 768, 658, 799, 626, 799], "text": "of"}, {"boundingBox": [665, 768, 750, 769, 750, 799, 664, 799], "text": "Totelle"}, {"boundingBox": [756, 769, 874, 768, 874, 800, 756, 799], "text": "products,"}, {"boundingBox": [880, 768, 1048, 768, 1048, 800, 880, 800], "text": "trimegestone,"}, {"boundingBox": [1054, 768, 1100, 768, 1099, 800, 1054, 800], "text": "has"}, {"boundingBox": [1106, 768, 1164, 768, 1163, 801, 1105, 800], "text": "high"}, {"boundingBox": [1170, 768, 1264, 768, 1263, 801, 1169, 801], "text": "affinity"}, {"boundingBox": [1270, 768, 1320, 767, 1319, 801, 1269, 801], "text": "and"}, {"boundingBox": [1326, 767, 1456, 767, 1455, 802, 1325, 801], "text": "specificity"}]}, {"boundingBox": [302, 818, 1209, 820, 1208, 851, 301, 850], "text": "for progesterone receptors, with no androgenic and glucocorticoid activity", "words": [{"boundingBox": [303, 821, 337, 821, 336, 847, 302, 847], "text": "for"}, {"boundingBox": [342, 821, 503, 821, 502, 849, 341, 847], "text": "progesterone"}, {"boundingBox": [508, 821, 633, 821, 633, 850, 508, 849], "text": "receptors,"}, {"boundingBox": [638, 821, 693, 821, 693, 851, 638, 851], "text": "with"}, {"boundingBox": [698, 821, 731, 821, 730, 851, 698, 851], "text": "no"}, {"boundingBox": [738, 821, 875, 821, 874, 851, 737, 851], "text": "androgenic"}, {"boundingBox": [880, 821, 928, 821, 927, 852, 879, 851], "text": "and"}, {"boundingBox": [933, 821, 1111, 820, 1111, 851, 933, 852], "text": "glucocorticoid"}, {"boundingBox": [1116, 820, 1209, 820, 1209, 850, 1116, 851], "text": "activity"}]}, {"boundingBox": [252, 900, 1456, 901, 1455, 933, 251, 932], "text": "(3) Totelle use is associated with either an unchanged or decreased mean weight following", "words": [{"boundingBox": [252, 902, 295, 902, 296, 931, 253, 931], "text": "(3)"}, {"boundingBox": [302, 902, 391, 902, 392, 931, 304, 931], "text": "Totelle"}, {"boundingBox": [398, 902, 447, 902, 448, 931, 399, 931], "text": "use"}, {"boundingBox": [455, 902, 485, 902, 485, 931, 456, 931], "text": "is"}, {"boundingBox": [490, 902, 624, 902, 624, 931, 491, 931], "text": "associated"}, {"boundingBox": [633, 902, 690, 903, 691, 931, 634, 931], "text": "with"}, {"boundingBox": [702, 903, 780, 903, 781, 931, 702, 931], "text": "either"}, {"boundingBox": [786, 903, 820, 903, 820, 931, 786, 931], "text": "an"}, {"boundingBox": [829, 903, 968, 902, 968, 931, 829, 931], "text": "unchanged"}, {"boundingBox": [978, 902, 1011, 902, 1011, 932, 978, 932], "text": "or"}, {"boundingBox": [1023, 902, 1145, 902, 1144, 932, 1023, 932], "text": "decreased"}, {"boundingBox": [1152, 902, 1223, 902, 1222, 932, 1152, 932], "text": "mean"}, {"boundingBox": [1235, 902, 1327, 901, 1326, 933, 1234, 932], "text": "weight"}, {"boundingBox": [1333, 901, 1456, 901, 1455, 934, 1332, 933], "text": "following"}]}, {"boundingBox": [300, 952, 547, 955, 547, 983, 299, 980], "text": "initiation of therapy", "words": [{"boundingBox": [300, 955, 409, 956, 410, 980, 301, 979], "text": "initiation"}, {"boundingBox": [419, 956, 447, 956, 447, 981, 419, 980], "text": "of"}, {"boundingBox": [451, 956, 545, 955, 545, 983, 452, 981], "text": "therapy"}]}, {"boundingBox": [492, 2040, 1188, 2042, 1187, 2075, 491, 2073], "text": "THE PARTHENON PUBLISHING GROUP", "words": [{"boundingBox": [496, 2042, 562, 2042, 564, 2074, 498, 2074], "text": "THE"}, {"boundingBox": [581, 2042, 800, 2043, 801, 2074, 582, 2074], "text": "PARTHENON"}, {"boundingBox": [818, 2043, 1039, 2042, 1040, 2075, 820, 2074], "text": "PUBLISHING"}, {"boundingBox": [1060, 2042, 1186, 2042, 1187, 2076, 1061, 2075], "text": "GROUP"}]}, {"boundingBox": [18, 2202, 497, 2204, 496, 2232, 17, 2231], "text": "Confidential Pursuant to Confidentiality", "words": [{"boundingBox": [21, 2203, 166, 2204, 167, 2231, 23, 2230], "text": "Confidential"}, {"boundingBox": [171, 2204, 285, 2204, 286, 2232, 172, 2231], "text": "Pursuant"}, {"boundingBox": [290, 2204, 316, 2204, 317, 2232, 291, 2232], "text": "to"}, {"boundingBox": [321, 2204, 495, 2204, 495, 2232, 322, 2232], "text": "Confidentiality"}]}, {"boundingBox": [1454, 2203, 1689, 2199, 1690, 2227, 1454, 2231], "text": "OLIVS019-018102", "words": [{"boundingBox": [1456, 2203, 1685, 2200, 1685, 2228, 1457, 2231], "text": "OLIVS019-018102"}]}, {"boundingBox": [25, 2239, 94, 2239, 95, 2260, 27, 2262], "text": "Order", "words": [{"boundingBox": [26, 2238, 93, 2237, 93, 2260, 26, 2261], "text": "Order"}]}, {"boundingBox": [374, 2237, 1322, 2236, 1322, 2275, 375, 2277], "text": "Source: https://www.industrydocuments.ucsf.edu/docs/ttdw0217", "words": [{"boundingBox": [379, 2241, 494, 2241, 495, 2274, 380, 2273], "text": "Source:"}, {"boundingBox": [501, 2241, 1321, 2236, 1321, 2274, 502, 2275], "text": "https://www.industrydocuments.ucsf.edu/docs/ttdw0217"}]}]}]}